Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW-856553 and endothelial function in dyslipidaemia
2006-005227-42Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lipid disorder and atherosclerosis comparing GW-856553 with Placebo (2 arms). Primary endpoint: Endothelium-dependent vasodilation (primary). Started Mar 2007; status: completed.
02
Drugs
losmapimod
03
Conditions
lipid disorderatherosclerosis
Beyond the preview
Go deeper on 2006-005227-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005227-42.